Delivered at Health Connect Partners conference in Chicago October 17, 2016. The presentation covers some of the current technology used in acute care pharmacies, as well as some technologies that I believe, have the potential to change the way pharmacists will practice in the near future.
6. Pharmacy practice, especially practice
within the acute care setting, is largely
unchanged from what it was 30 years
ago. While it can be asserted that new
drugs have entered the market, more
pharmacists spend some or all of their
time in clinical practice, and, to some
degree, new technologies have become
available, too many pharmacists
continue to practice in the acute care
settings that provide roughly the same
services, using the same practice model
now, that they did in 1976....an obsolete
practice model.
“
Technology-enabled practice: A vision statement by the ASHP Section of Pharmacy Informatics and
Technology Am J Health Syst Pharm 2009 66: 1573-1577
7. "You know, like nunchuck skills, bo hunting skills, computer hacking skills. Girls
only like guys who have great skills." - Napoleon Dynamite
8. Medication Errors
Medication Errors That
Adversely Affect Patient
Care Outcomes
Net No. of Favorable
Outcomes Associated
with Each Variable
Pharmacist location
Decentralized ↓ ↓ 5
Centralized with ward visits ↑ ↑ -2
Centralized ↑ ↑ -2
Adopted from Table 4 - Clinical Pharmacy Services in U.S. Hospitals in 2020 Bond et al, Pharmacotherapy 2004
19. Sources: U.S. Bureau of the Census (1970 and various years); Cellular Telecommunications Industry Association (1996); The World Almanac and Book of Facts (1997) - http://www.glencoe.com/sec/socialstudies/economics/econtoday2001/pdfs/C22-02C-820489.pdf
20. Adoption of Smartpumps, BCMA, CPOE graphed as percent adoption over time (data source: AJHP - Vol 72 Jul 1, 2015)
Graph: Jerry Fahrni, Pharm.D. – All rights reserved
21. Have a clear, unambiguous advantage in either effectiveness or cost-effectiveness
Are compatible with the adopter’s values, norms, and perceived needs
Are perceived as simple to use
Knowledge to use innovation can be codified and transferred easily
When the technology can be refined and modified by the adopter to meet their specific needs
Carries a low degree of uncertainty, i.e. they are perceived as having little risk.
Observable benefits
It is relevant to the user’s work and improves task performance
Offer trialability - users can experiment on a limited basis
Technology offered as an “augmented product”
Greenhalgh, et al. The Milbank Quarterly, 82(4), 581–629.
27. External sensors - blood-pressure cuffs and pulse oximeters
Wearables embedded in clothing or accessories
Epidermal sensors, such as patches and digital tattoos
Ingestibles embedded in pills that dissolve
Tissue-embedded sensors - pacemakers and defibrillators
Blood-sampling sensors, such as glucose meters
30. Selectively perforate bacterial cell membrane without affecting host cells
Release antibiotic in presence of infection
Target antibiotic to attack specific bacterial antigens
Gold coated nano shells heated up with light to destroy cancer cells
(Nanobullet)
Smart Insulin – “Glucose Sensitive Insulin”
Nano-artificial pancreas
Biodegradable nanoparticles that release growth factors and angiogenic
factors to improve bioengineering of heart or lung tissue
34. Professionals entrusted with the delivery and
administrations of pharmaceuticals have a
fundamental responsibility
to identify and implement interventions that will
improve patient quality outcome measures and also
reduce overall health-care costs. These interventions
include timely and judicious use of
therapeutic and technological advances
Meyer GE, et al. AJHP. 1991 May 1;48:953-966
“
35. THE FUTURE OF PHARMACY: Using Technology to Drive Practice Change
Jerry Fahrni, Pharm.D. || 559.838.6014 || @JFahrni
Editor's Notes
Image source: http://hypothyroidmom.com/wp-content/uploads/2013/10/chicken-and-egg3.jpg [Licensed under creative commons]
Bond CA, Raehl CL, Patry R. Evidence-Based Core Clinical Pharmacy Services in United States Hospitals in 2020: Services and Staffing, Pharmacotherapy 2004; 24(4):427-440 …. Adopted from Table 4 - Summary of Statistically Significant Associations of Clinical Pharmacy Services, Hospital Pharmacy Staffing, and Pharmacist Location with Major Health Care Outcomes in Clinical Pharmacy Services in U.S. Hospitals in 2020 Bond et al, Pharmacotherapy 2004
Strong Memorial Hospital (SMH) - part of the University of Rochester Medical Center (URMC) complex, in Rochester, New York –
DIFFUSION OF INNOVATION THEORY - developed by E.M. Rogers in 1962.
[Rogers, E. M. & Shoemaker, F. F. (1971). Communication of Innovation. New York: The Free Press.]
Harvard Business Review,. "The Pace Of Technology Adoption Is Speeding Up". N.p., 2013. Web. 20 Jan. 2016.
[Greenhalgh, T., Robert, G., Macfarlane, F., Bate, P., and Kyriakidou, O. (2004). Diffusion of Innovations in Service Organizations: Systematic Review and Recommendations. The Milbank Quarterly, 82(4), 581–629. http://doi.org/10.1111/j.0887-378X.2004.00325.x]
https://en.wikipedia.org/wiki/Transferase
licensed under the Creative Commons Attribution-Share Alike 3.0 Unported
First mobile insulin pump ... 1963
http://www.computerworld.com/article/3048823/3d-printing/this-is-the-first-3d-printed-drug-to-win-fda-approval.html
3-Dimensional Drug Printing: Potential in the Pharmacy:
http://www.pharmacytimes.com/publications/issue/2013/august2013/3-dimensional-drug-printing-potential-in-the-pharmacy#sthash.GgD3f048.dpuf
Three-dimensional drug printing: A structured review
http://www.japha.org/article/S1544-3191(15)30306-X/abstract
No need for the pharmacy; just press print [video – theophylline tablet]
http://scienceline.org/2014/12/no-need-for-the-pharmacy-just-press-print/
“Professionals entrusted with the delivery and administrations of pharmaceuticals have a fundamental responsibility (moral obligation—MN) to identify and implement interventions that will improve patient quality outcome measures and also reduce overall health-care costs. These interventions include the timely and judicious use of therapeutic and technological advances.”
Meyer GE, Brandell R, Smith JE, et al. "Use of bar codes in inpatient drug distribution" Am J Health Syst Pharm. 1991 May 1;48:953-966